High Throughput News and Research

RSS
Researchers discover new details of how autoantibodies destroy healthy cells in skin

Researchers discover new details of how autoantibodies destroy healthy cells in skin

Dell, Terascala and TGen to install genomic data management solution at NCI

Dell, Terascala and TGen to install genomic data management solution at NCI

New project aims at delivering innovative test to improve safety of chemical products, drugs

New project aims at delivering innovative test to improve safety of chemical products, drugs

Protein RBM4 drastically decreases multiple forms of human cancer

Protein RBM4 drastically decreases multiple forms of human cancer

Chromatin immunoprecipitation informative brochure published by Porvair Sciences

Chromatin immunoprecipitation informative brochure published by Porvair Sciences

Two fully automated molecular testing systems for blood and plasma donor screening launched by Roche

Two fully automated molecular testing systems for blood and plasma donor screening launched by Roche

Agfa HealthCare’s digital radiography technologies selected by Summa Health System

Agfa HealthCare’s digital radiography technologies selected by Summa Health System

Scientists identify number of compounds to treat cancer could add to anti-malarial arsenal

Scientists identify number of compounds to treat cancer could add to anti-malarial arsenal

Newborn screening for SCID holds promise that affected children can lead healthy lives

Newborn screening for SCID holds promise that affected children can lead healthy lives

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

Cellular Research announces start of early access program for Precise assays

Cellular Research announces start of early access program for Precise assays

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

Leica Biosystems, ACD co-market RNAscope LS ISH assays and BOND RX instrument

Leica Biosystems, ACD co-market RNAscope LS ISH assays and BOND RX instrument

Vitro toxicity testing an alternative to predict adverse health effects of drugs

Vitro toxicity testing an alternative to predict adverse health effects of drugs

Researchers develop new methods to identify genes important for survival of MRSA in pigs

Researchers develop new methods to identify genes important for survival of MRSA in pigs

Engineers create truly portable device for nuclear magnetic resonance spectroscopy

Engineers create truly portable device for nuclear magnetic resonance spectroscopy

New web-based tool enables researchers to quickly visualize genomic information

New web-based tool enables researchers to quickly visualize genomic information

Computational biologists develop program for easy diagnosis of hereditary illnesses

Computational biologists develop program for easy diagnosis of hereditary illnesses

VCU awarded $3 million grant to study how childhood adverse experiences create long-term health risks

VCU awarded $3 million grant to study how childhood adverse experiences create long-term health risks

Researchers identify molecular mechanisms of cognitive decline using high-throughput proteomics

Researchers identify molecular mechanisms of cognitive decline using high-throughput proteomics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.